21 – 40 of 52
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.
(
- Contribution to journal › Article
- 2014
-
Mark
Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.
(
- Contribution to journal › Article
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study.
(
- Contribution to journal › Article
-
Mark
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.
(
- Contribution to journal › Article
-
Mark
Increased Levels of Hyaluronic Acid in Cerebrospinal Fluid in Patients with Vascular Dementia.
(
- Contribution to journal › Article
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
2014) In Journal of Alzheimer's Disease(
- Contribution to journal › Article
- 2013
-
Mark
Evaluating Amyloid-beta Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Modern demensvård på gång tack vare nationella riktlinjer
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia
(
- Contribution to journal › Article
-
Mark
Diabetes Mellitus and Elevated Copeptin Levels in Middle Age Predict Low Cognitive Speed after Long-Term Follow-Up.
(
- Contribution to journal › Article
-
Mark
Evaluation of the Cerebrospinal Fluid Amyloid-beta(1-42)/Amyloid-beta(1-40) Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
(
- Contribution to journal › Article
-
Mark
Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia
(
- Contribution to journal › Article
-
Mark
A longitudinal study of semantic memory impairment in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
ROI-based analysis of diffusional kurtosis estimates for identification of MCI-patients at high risk for conversion to Alzheimer’s disease in a heterogeneous MCI cohort
2013) ISMRM, 2013(
- Contribution to conference › Poster
- 2012
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
Diffusion tensor tractography of the posterior cingulate gyrus and corpus callosum does not identify MCI-patients at high risk for conversion to Alzheimer’s disease in a heterogeneous MCI cohort
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Health-related factors associated with hospitalization for old people: Comparisons of elderly aged 85 in a population cohort study.
(
- Contribution to journal › Article
- 2011
-
Mark
Atrial fibrillation (AF) and co-morbidity in elderly. A population based survey of 85 years old subjects
(
- Contribution to journal › Article
-
Mark
Association between Subcortical Lesions and Behavioral and Psychological Symptoms in Patients with Alzheimer's Disease.
(
- Contribution to journal › Article